Hexagon Capital Partners’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-124	Closed	-$2.21K	–	1168
2025 Q1	$2.21K	Buy	124 +112	+933%	+$2K	﹤0.01%	1377
2024 Q4	$358	Buy	12 +8	+200%	+$239	﹤0.01%	1724
2024 Q3	$63	Buy	+4	New	+$63	﹤0.01%	1555